Safety, Tolerability and Pharmacokinetics of FTX-6058

Clinical trial NCT04586985 · COMPLETED

Trial details

NCT number: NCT04586985
Sponsor: Fulcrum Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Subjects Sickle Cell Disease

Start date: 2020-10-26
Primary completion: 2022-11-15
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.